ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 86 filers reported holding ANTARES PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $136,000 | +22.5% | 33,238 | +6.6% | 0.00% | – |
Q4 2021 | $111,000 | +19.4% | 31,184 | +22.0% | 0.00% | -100.0% |
Q3 2021 | $93,000 | +3.3% | 25,560 | +23.3% | 0.00% | – |
Q2 2021 | $90,000 | +25.0% | 20,735 | +17.6% | 0.00% | – |
Q1 2021 | $72,000 | +26.3% | 17,634 | +22.6% | 0.00% | – |
Q4 2020 | $57,000 | +90.0% | 14,386 | -18.4% | 0.00% | – |
Q3 2015 | $30,000 | +172.7% | 17,634 | +225.8% | 0.00% | – |
Q2 2015 | $11,000 | +10.0% | 5,413 | +50.7% | 0.00% | – |
Q1 2015 | $10,000 | +11.1% | 3,592 | +1.0% | 0.00% | – |
Q4 2014 | $9,000 | +28.6% | 3,557 | -8.0% | 0.00% | – |
Q3 2014 | $7,000 | -36.4% | 3,866 | -9.5% | 0.00% | – |
Q2 2014 | $11,000 | -21.4% | 4,273 | +4.9% | 0.00% | – |
Q1 2014 | $14,000 | -22.2% | 4,075 | +1.0% | 0.00% | – |
Q4 2013 | $18,000 | -67.9% | 4,034 | -70.5% | 0.00% | – |
Q3 2013 | $56,000 | +86.7% | 13,694 | +89.0% | 0.00% | – |
Q2 2013 | $30,000 | – | 7,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |